| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
229,860,000 |
| Market
Cap: |
418.35(M) |
| Last
Volume: |
562,074 |
Avg
Vol: |
228,218 |
| 52
Week Range: |
$1.45 - $5.46 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 4.1 |
| Insider 6 Months : 4.1 |
| Insider 3/6 Months : 8.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Palatin Technologies is a biopharmaceutical company developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Co.'s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Co.'s primary product, Vyleesi®, is a melanocortin receptor agonist, is an as needed therapy used in anticipation of sexual activity and self-administered in the thigh or abdomen via a single-use subcutaneous auto-injector by premenopausal women with hypoactive sexual desire disorder.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
6,000 |
6,000 |
6,000 |
26,000 |
| Total Buy Value |
$12,703 |
$12,703 |
$12,703 |
$57,245 |
| Total People Bought |
1 |
1 |
1 |
3 |
| Total Buy Transactions |
1 |
1 |
1 |
3 |
| Total Shares Sold |
11,700 |
16,898 |
16,898 |
16,898 |
| Total Sell Value |
$23,434 |
$36,493 |
$36,493 |
$36,493 |
| Total People Sold |
1 |
3 |
3 |
3 |
| Total Sell Transactions |
1 |
3 |
3 |
3 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dunton Alan W |
Director |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
195,645 |
|
- |
|
| Rossetti Angela |
Director |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
140,625 |
|
- |
|
| Prendergast John K A |
Director |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
466,767 |
|
- |
|
| Wills Stephen T |
Executive VP and CFO/COO |
• • – |
2016-06-13 |
4 |
D |
$0.49 |
$14,161 |
D/D |
(28,899) |
1,392,453 |
|
- |
|
| Wills Stephen T |
Executive VP and CFO/COO |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,000 |
1,421,352 |
|
- |
|
| Morris Arlene |
Director |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
80,625 |
|
- |
|
| Deveer Robert K Jr |
Director |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
294,685 |
|
- |
|
| Spana Carl |
President and CEO |
• • – |
2016-06-13 |
4 |
D |
$0.49 |
$19,021 |
D/D |
(38,819) |
1,520,520 |
|
- |
|
| Spana Carl |
President and CEO |
• • – |
2016-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
105,000 |
1,559,339 |
|
- |
|
| Hull Joseph Stanley |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
245,625 |
|
- |
|
| Dunton Alan W |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
175,645 |
|
- |
|
| Rossetti Angela |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
120,625 |
|
- |
|
| Prendergast John K A |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
426,767 |
|
- |
|
| Morris Arlene |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
60,625 |
|
- |
|
| Deveer Robert K Jr |
Director |
• • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
274,685 |
|
- |
|
| Deveer Robert K Jr |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
275,726 |
|
- |
|
| Prendergast John K A |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
428,849 |
|
- |
|
| Hull Joseph Stanley |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
246,666 |
|
- |
|
| Spana Carl |
President and CEO |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
325,000 |
1,623,089 |
|
- |
|
| Rossetti Angela |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
101,666 |
|
- |
|
| Morris Arlene |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
31,666 |
|
- |
|
| Wills Stephen T |
Executive VP and CFO/COO |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
1,483,852 |
|
- |
|
| Horovitz Zola P |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
250,666 |
|
- |
|
| Dunton Alan W |
Director |
• • – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
166,686 |
|
- |
|
| Hull Joseph Stanley |
Director |
• • – |
2015-12-04 |
4 |
B |
$0.66 |
$1,652 |
D/D |
2,500 |
21,500 |
2.31 |
- |
|
174 Records found
|
|
Page 6 of 7 |
|
|
0.10 (5.81%) 
